Healthcare and the End of Antitrust Safety Zones: Increased Scrutiny of Information Exchanges, Collaborations, Mergers
Recording of a 90-minute CLE video webinar with Q&A
This CLE webinar will guide healthcare counsel on the changing landscape for antitrust enforcement in the healthcare sector. The panel will discuss the Department of Justice's withdrawal of three long-standing antitrust policy statements related to enforcement in healthcare and what this means for the healthcare industry. The panel will offer best practices for navigating collaborations and transactions in light of the end of the antitrust safe harbors.
Outline
- DOJ's withdrawal of three long-standing antitrust policy statements
- Implications for healthcare
- Best practices for navigating collaborations and transactions
Benefits
The panel will review these and other key issues:
- What does the end of the safe harbors mean for healthcare?
- What is the impact on competitor collaborations or mergers?
- What steps should healthcare companies and their counsel take to ensure antitrust compliance?
Faculty
Lauren N. Donahue
Partner
K&L Gates
Ms. Donahue practices in the firm’s antitrust, competition and trade regulation and investigations, enforcement... | Read More
Ms. Donahue practices in the firm’s antitrust, competition and trade regulation and investigations, enforcement and white collar practice groups. She focuses her practice on domestic and international internal investigations, corporate criminal defense, complex commercial litigation, and antitrust counseling. Ms. Donahue has extensive experience representing clients in international and domestic cartel and fraud investigations and related class actions. Her cases involve a wide range of issues, including price-fixing, market allocation, bid-rigging, no-poach agreements, monopolization, fraud, unfair competition and other restraints of trade. Ms. Donahue has conducted numerous domestic and global internal investigations for major corporations across a variety of industries. She regularly defends corporations and individuals who are subjects of federal and state grand jury subpoenas, cross-border investigations and enforcement proceedings.
Close
John R. Ingrassia
Partner
Proskauer Rose
Mr. Ingrassia advises on the full range of antitrust matters in diverse industries, including chemicals,... | Read More
Mr. Ingrassia advises on the full range of antitrust matters in diverse industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services and health care, among others. His practice focuses on the analysis and resolution of antitrust issues related to mergers, acquisitions, and joint ventures, and the analysis and assessment of pre-merger notification requirements. Mr. Ingrassia has extensive experience with the legal, practical, and technical requirements of merger clearance and is regularly invited to participate in Federal Trade Commission and bar association meetings regarding Hart-Scott-Rodino practice issues.
Close
Gerald A. Stein
Partner
Norton Rose Fulbright US
Mr. Stein’s comprehensive career as an antitrust litigator and as a former attorney with the Bureau of... | Read More
Mr. Stein’s comprehensive career as an antitrust litigator and as a former attorney with the Bureau of Competition at the FTC enables him to represent and counsel clients in a full array of antitrust matters including federal and state litigation, class action and multidistrict litigation, and federal and state antitrust enforcement proceedings in all industries. He also provides strategic antitrust merger and acquisition analysis, counseling, and compliance, and represents clients as targets or non-party witnesses in federal and state government investigations and proceedings. Mr. Stein has represented major corporations in all aspects of commercial litigation and private antitrust actions involving alleged violations of Sherman Act Sections 1 and 2 regarding claims of price fixing, monopolization, boycotts, refusals to deal, and unfair and deceptive trade practices in various industries. In addition to his litigation practice, Mr. Stein counsels and represents major companies with respect to antitrust compliance and transactional work in a wide variety of industries including hospital systems, physician practice groups, and medical devices.
Close